Baillie Gifford exit CRISPR Therapeutics AG
Baillie Gifford exit $-17.1M of disclosed value in CRISPR Therapeutics AG.
Signal
Investor Move
Action
Exit
Capital
$-17.1M disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.